[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-268958-105":59,"doc-detail-268958-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","2026-stars-measures-part-c-measures-hedis-ncqa","2026 STARS MEASURES - PART C MEASURES (HEDIS, NCQA)","","2026 STARS Measures Part C (HEDIS, NCQA) compiles clinical quality measures with measure IDs, definitions, weighting (WT), eligible age ranges, and reporting date ranges. It covers key outcomes across hypertension control, breast cancer screening, fecal and colorectal cancer testing, osteoporosis fracture follow-up, transitions of care medication reconciliation and engagement, statin adherence for ASCVD, diabetes glycemic status, eye and kidney evaluations. It also lists Care for Older Adults SNP measures for functional status assessment and medication review requirements.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/2026-stars-measures-part-c-measures-hedis-ncqa/268958/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/2026-stars-measures-part-c-measures-hedis-ncqa/268958.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-15",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What information does the 2026 STARS Measures Part C table provide for each measure?","Question",{"text":113,"@type":114},"For each measure, it lists the measure ID, description, weighting (WT), eligible age range, and the applicable date range for the measurement period.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which Part C measures address blood pressure and fracture-related osteoporosis follow-up?",{"text":118,"@type":114},"CBP covers hypertension control, and OMW addresses follow-up after fractures with either a bone mineral density test or a prescription for osteoporosis medication within the required window.",{"name":120,"@type":111,"acceptedAnswer":121},"What transitions of care indicators are included in Part C?",{"text":122,"@type":114},"TRC-MRP captures documentation of medication reconciliation around inpatient discharge within the specified 31-day total window, and TRC-PE captures patient engagement documentation within 30 days after discharge (excluding engagement on the discharge day).",{"name":124,"@type":111,"acceptedAnswer":125},"What older adult SNP measures are listed under Care for Older Adults (COA)?",{"text":126,"@type":114},"COA FSA requires a functional status assessment during the measurement year, and COA MED REV requires a medication review supported by presence of a medication list in the medical record.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},268958,1789439501,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":14,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":134,"read_time":24},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","| 2026 STARS MEASURES |  |  |  |  |\n| --- | --- | --- | --- | --- |\n| PART C MEASURES (HEDIS, NCQA) |  |  |  |  |\n| Measure MEASURE DESCRIPTION WT. AGE DATE RANGE |  |  |  |  |\n| CBP | Members diagnosed with hypertension (HTN) whose blood pressure (BP) was controlled (\u003C140/90 mm Hg) | 3.0 | 18-85 | Jan 1, 2026 to Dec 31, 2026 (yearly) |\n| BCS-E | Breast Cancer Screening (Mammography or Exclusion) | 1.0 | 40-74 | Oct 1, 2024 to Dec 31, 2026 (27 months) |\n| COL-E | iFOBT/gFOBT-Fecal occult blood test | 1.0 | 45-75 | Jan 1, 2026 to Dec 31, 2026 (yearly) |\n|  | Flexible sigmoidoscopy | CT Colonography |  |  | Jan 1, 2022 to Dec 31, 2026 (5 years) |\n|  | Colonoscopy |  |  | Jan 1, 2017 to Dec 31, 2026 (10 years) |\n|  | FIT-DNA Test |  |  | Jan 1, 2024 to Dec 31, 2026 (3 years) |\n| OMW | The percentage of women who suffered a fracture and who had either a bone mineral density (BMD) test OR prescription for a drug to treat osteoporosis in the 180 days (6 months) after the fracture. | 1.0 | 67-85 | Jul 1, 2025 to Jun 30, 2026 (yearly) |\n| TRC-MRP* | Percentage of members with an acute or non-acute inpatient discharge on or between Jan. 1–Dec. 1 of the measurement year with medication reconciliation documented on the date of the discharge through 30 days after the discharge (31 days total) . | 0.25 | ≥18 | Jan 1, 2026 to Dec 1, 2026 (yearly) |\n| TRC-PE* | Percentage of members with acute or non-acute inpatient discharges on or between Jan. 1—Dec. 1 of the measurement year with engagement documented within 30 days of the discharge. Do not include patient engagement that happens on the day of discharge. | 0.25 | ≥18 | Jan 1, 2026 to Dec 1, 2026 (yearly) |\n| SPC | Patients diagnosed with ASCVD who were dispensed high-intensity or moderate-intensity statin medications and remained on these medications for at least 80% of the treatment period | 0.0 | 21-75 | Jan 1, 2026 to Dec 31, 2026 (yearly) |\n| GSD | Members with Type 1 or Type 2 diabetes whose most recent glycemic status (measured by hemoglobin A1c [HbA1c] or glucose management indicator [GMI]) was either below 8.0% or above 9.0% during the measurement year. (Good control is defined as \u003C8%) | 3.0 | 18-75 | Jan 1, 2026 to Dec 31, 2026 (yearly) |\n| EED** | Percentage of members with diabetes who had an eye exam (retinal) to check for damage from diabetes during the measurement year or had a negative eye exam in prior year. | 1.0 | 18-75 | Jan 1, 2026 to Dec 31, 2026 (yearly) |\n| KED | The percentage of members 18–85 years of age with diabetes (type 1 and type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) AND a urine albumincreatinine ratio (uACR), during the measurement year. | 1.0 | 18-85 | Jan 1, 2026 to Dec 31, 2026 (yearly) |\n| PCR | The risk-adjusted ratio of observed-to-expected unplanned acute readmissions (inpatient and observation stays) for any diagnosis within 30 days of an acute hospitalization (inpatient and observation stays) for members ages 18 and older. A lower rate indicates a better score for this measure. | 3.0 | ≥18 | Jan 1, 2026 to Dec 31, 2026 (yearly) |\n| FMC | The percentage of emergency department (ED) visits for members 18 years of age and older who have multiple high-risk chronic condistions who had a follow-up service within 7 days of the ED visit. | 0.0 | ≥18 | Jan 1, 2026 to Dec 31, 2026 (yearly) |\n| CARE FOR OLDER ADULTS (COA) SNP MEMBERS 66 AND OLDER |  |  |  |  |\n| COA FSA | Functional Status Assessment during measurement year | 1.0 | SNP ≥ 66 | Jan 1, 2026 to Dec 31, 2026 (yearly) |\n| COA MED REV | Medication review w/ presence of a medication list in the medical record (needs to include both to close gap) | 1.0 | SNP ≥ 66 | Jan 1, 2026 to Dec 31, 2026 (yearly) |\n\n| PART D MEASURES (PQA) |  |  |  |  |\n| --- | --- | --- | --- | --- |\n| COB | Percentage of Medicare Part D beneficiaries ages 18 and older with concurrent use of prescription opioids and benzodiazepines. Lower Rates represent better perf","cbCaihiE1CGhymIO","https://ap.wps.com/l/cbCaihiE1CGhymIO","pdf",394916,"English","# 2026 STARS MEASURES\n## PART C MEASURES (HEDIS, NCQA)\n## PART D MEASURES (PQA)","[{\"question\":\"What information does the 2026 STARS Measures Part C table provide for each measure?\",\"answer\":\"For each measure, it lists the measure ID, description, weighting (WT), eligible age range, and the applicable date range for the measurement period.\"},{\"question\":\"Which Part C measures address blood pressure and fracture-related osteoporosis follow-up?\",\"answer\":\"CBP covers hypertension control, and OMW addresses follow-up after fractures with either a bone mineral density test or a prescription for osteoporosis medication within the required window.\"},{\"question\":\"What transitions of care indicators are included in Part C?\",\"answer\":\"TRC-MRP captures documentation of medication reconciliation around inpatient discharge within the specified 31-day total window, and TRC-PE captures patient engagement documentation within 30 days after discharge (excluding engagement on the discharge day).\"},{\"question\":\"What older adult SNP measures are listed under Care for Older Adults (COA)?\",\"answer\":\"COA FSA requires a functional status assessment during the measurement year, and COA MED REV requires a medication review supported by presence of a medication list in the medical record.\"}]","2026 STARS MEASURES - PART C MEASURES (HEDIS, NCQA) | PDF"]